ncRNA name
POU3F3
Specific or universal ncRNAs
Specific ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
MiR-650/MGMT
Cancer name
Melanoma
Cancer site
qRT-PCR,Western blot,Luciferase assay
Treatment type
Chemotherapy
Drug
Dacarbazine
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
198
Male patients
111
Female patients
155(<60)+154(>=60)
Age range and number
Not available
PMID
Description
LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis
Tissue resource
human melanoma cell lines A375
human melanoma cell lines MV3
Experiment
309
Institute
American Type Culture Collection
Country
United States
Continent
North Amercian